Ultragenyx to Present at Bank of America Securities Healthcare Conference
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Mardi Dier, Chief Financial Officer, and Camille Bedrosian, M.D., Chief Medical Officer, will present at the BofA Securities Healthcare Conference on May 12, 2021, at 3:30 PM ET. The live webcast can be accessed from the company's website, with a replay available for 90 days. Ultragenyx focuses on developing therapies for rare genetic diseases and has a diverse portfolio of approved medicines aimed at addressing high unmet medical needs.
- None.
- None.
NOVATO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Mardi Dier, the company's Chief Financial Officer and Camille Bedrosian, M.D., the company’s Chief Medical Officer, will present at the BofA Securities Healthcare Conference on Wednesday, May 12, 2021 at 3:30 PM ET.
The live and archived webcast of the presentation will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 90 days.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing to patients novel therapies for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved medicines and treatment candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contact Ultragenyx Pharmaceutical Inc.
Investors & Media
Joshua Higa
415-475-6370
FAQ
When will Ultragenyx present at the BofA Securities Healthcare Conference?
Who will represent Ultragenyx at the BofA Healthcare Conference?
Where can I watch the Ultragenyx presentation?
What is the focus of Ultragenyx Pharmaceutical?
What is the stock symbol for Ultragenyx Pharmaceutical?
